Please login to the form below

Not currently logged in
Email:
Password:

brain cancer

This page shows the latest brain cancer news and features for those working in and with pharma, biotech and healthcare.

UK approval for Seagen’s oral HER2 inhibitor Tukysa

UK approval for Seagen’s oral HER2 inhibitor Tukysa

patients whose cancer had metastasised into the brain at the time they were enrolled in the study. ... The Tukysa combination is a landmark therapy for patients with HER2-positive metastatic breast cancer with or without brain metastases, extending

Latest news

More from news
Approximately 1 fully matching, plus 79 partially matching documents found.

Latest Intelligence

  • Cancer care – the power of new technologies Cancer care – the power of new technologies

    on the tumour type that they had, with brain cancer patients highlighting a significantly worse experience than for other tumour types. ... As people are living longer, more and more people will be living longer with cancer.

  • Deal Watch January 2018

    enhance blood-brain barrier (BBB) penetration of antibody molecules via the transferrin receptor. ... that is highly selective for HER2.  Tucatinib is currently being evaluated in a phase II pivotal trial in patients with HER2-positive metastatic

  • Sharing ideas to improve care for cancer patients – part 2 Sharing ideas to improve care for cancer patients – part 2

    Taking place on September, 4 at 1pm, the free, one-hour webinar will feature speakers from Bristol Testicular Cancer Service, Mount Vernon Cancer Centre and The Brain Tumour Charity. ... Theresa Sullivan, Macmillan Patient Information Lead, Mount Vernon

  • Sharing ideas to improve care for cancer patients – part 1 Sharing ideas to improve care for cancer patients – part 1

    from Bristol Testicular Cancer Service, Mount Vernon Cancer Centre and The Brain Tumour Charity. ... Title: Shout Out! magazine for 7-13 year olds with living with cancer.

  • Interview: Michel Goldman, Innovative Medicines Initiative Interview: Michel Goldman, Innovative Medicines Initiative

    And we do this by implementing proposals in different areas. For example, we have several projects on brain disorders, diabetes, cancer, inflammatory disorders and several projects on pulmonary diseases, to give

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....